- Home
- OLP vs BCYC Comparison
OLP vs BCYC Comparison
Compare OLP & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | BCYC |
|---|---|---|
| Founded | 1982 | 2009 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 478.2M | 476.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | OLP | BCYC |
|---|---|---|
| Price | $21.04 | $6.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $18.73 |
| AVG Volume (30 Days) | 112.4K | ★ 241.6K |
| Earning Date | 11-06-2025 | 02-24-2026 |
| Dividend Yield | ★ 8.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $97,423,000.00 | $28,339,000.00 |
| Revenue This Year | $7.95 | N/A |
| Revenue Next Year | $6.06 | N/A |
| P/E Ratio | $13.59 | ★ N/A |
| Revenue Growth | ★ 9.29 | N/A |
| 52 Week Low | $19.62 | $6.03 |
| 52 Week High | $28.36 | $15.47 |
Technical Indicators
Market Signals| Indicator | OLP | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 44.64 |
| Support Level | $19.94 | $6.30 |
| Resistance Level | $20.41 | $7.00 |
| Average True Range (ATR) | 0.38 | 0.31 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 65.51 | 36.92 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.